Japer Therapeutics Warrants
JSPRW
10 hedge funds and large institutions have $431K invested in Japer Therapeutics Warrants in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
677% more capital invested
Capital invested by funds: $55.5K → $431K (+$375K)
1.88% more ownership
Funds ownership: 3.45% → 5.34% (+1.9%)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
29% less funds holding
Funds holding: 14 → 10 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Capital
New York
|
+$91.9K |
| 2 |
CAC
Cowen and Company
New York
|
+$91.8K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
+$12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Ionic Capital Management
New York
|
-$29.4K |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
-$8.02K |
| 3 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$3.33K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$1K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$319 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAC
1
Cowen and Company
New York
| $132K | +$91.8K | +628,426 | +1,928% |
|
|
2
Walleye Capital
New York
| $131K | +$91.9K | +629,775 | +2,513% |
|
|
ICM
3
Ionic Capital Management
New York
| $51.6K | -$29.4K | -201,448 | -44% |
|
|
TCM
4
Tenor Capital Management
New York
| $50K | – | – | – |
|
|
HCM
5
Highbridge Capital Management
New York
| $26K | – | – | – |
|
|
CL
6
CSS LLC
Chicago,
Illinois
| $16.4K | +$12K | +81,957 | New |
|
|
ZA
7
Zazove Associates
Incline Village,
Nevada
| $12K | – | – | – |
|
|
EPM
8
Equitec Proprietary Markets
Chicago,
Illinois
| $8.97K | -$146 | -1,000 | -2% |
|
9
Walleye Trading
New York
| $2.82K | – | – | – |
|
10
Osaic Holdings
Scottsdale,
Arizona
| $10 | – | – | – |
|
|
OCAM
11
Owl Creek Asset Management
New York
| – | -$8.02K | -267,189 | Closed |
|
|
PFM
12
Privium Fund Management
Amsterdam,
Netherlands
| – | -$3.33K | -98,202 | Closed |
|
|
SCM
13
Shaolin Capital Management
Miami,
Florida
| – | -$1K | -20,420 | Closed |
|
|
WAM
14
Wolverine Asset Management
Chicago,
Illinois
| – | -$319 | -10,646 | Closed |
|
JSPRW Hedge Fund Activity: Q1 2023 in Review
10 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2023, worth a combined $431K — up 677% from $55.5K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of JSPRW and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Walleye Capital, adding an estimated $91.9K. The largest seller was Ionic Capital Management, cutting an estimated $29.4K.
- 10 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2023, down from 14 in Q4 2022.
- Funds reported $431K of Japer Therapeutics Warrants stock for Q1 2023, up 677% quarter-over-quarter.
- 1 fund opened new Japer Therapeutics Warrants positions in Q1 2023 and 5 closed out, a net change of -4 holders.
- The largest Japer Therapeutics Warrants buyer in Q1 2023 was Walleye Capital, an estimated $91.9K added.
- The largest Japer Therapeutics Warrants seller in Q1 2023 was Ionic Capital Management, an estimated $29.4K sold.
Based on aggregated 13F filings for Q1 2023.